No, you cannot drive after Spravato treatment on the day of your session. Sedation, dissociation, and dizziness can linger for hours, so you must arrange a responsible person to take you home. Wait until the next day, after a full night of sleep, before you get behind the wheel.
Spravato (esketamine) can be an effective option for adults with treatment-resistant depression, but it comes with strict safety protocols. This guide covers why driving is restricted, what a session feels like, and how to plan rides and rest until the following morning.
Spravato is an FDA-approved prescription nasal spray containing esketamine, which is given only in a certified clinic – you cannot pick it up at a pharmacy or take it home.
It is indicated for adults with treatment-resistant depression who have not improved enough on other antidepressants.
It is also approved for depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions.
Unlike daily pills that act slowly on serotonin, Spravato acts on a glutamate pathway and can reduce symptoms more rapidly for some patients.
Treatment usually lasts several months, and many patients continue for a year or more. Visits are more frequent early on, so build a ride into every appointment from day one.
Find a Spravato Provider in Your Area
After you self-administer the spray, you remain in the clinic for a mandatory observation period of at least two hours, as required by the Spravato REMS program.
Staff check on you and monitor blood pressure at regular intervals.
You are not discharged until your provider determines you are clinically stable.
“Stable enough to leave” is not the same as “safe to drive.” You can ride in a passenger seat and still be too impaired to operate a car.
Move from sitting to standing slowly, and let staff help you to your ride if you feel unsteady.
Do not stack childcare pickup, a work meeting, or another appointment right after. A Spravato day is a treatment day.
The answer is an unequivocal no. This is a strict safety mandate from the FDA and the manufacturer as part of the Spravato REMS program – not a suggestion.
Driving requires clear judgment, sharp focus, fast reaction times, and precise motor coordination. Spravato can temporarily impair all of these.
Sedation and drowsiness: Can slow braking and steering.
Dizziness and vertigo: Makes it harder to control the vehicle and judge distances.
Dissociation: Can make traffic, road signs, and your own speed feel distant or less real.
Cognitive and motor impairment: Can linger even after the strongest feelings fade.
There are no exceptions for short distances or empty parking lots. Arrive as a passenger. Leave as a passenger.
Do not drive, operate heavy machinery, or do other activities that require mental alertness for the rest of the day after treatment. Wait until the morning after a full, restful night of sleep.
Do not drive later the same evening, even if you feel alert after observation.
Coffee, a cold shower, or fresh air may make you feel more awake but do not restore judgment and reaction speed.
The wait is the same after visit one and visit twenty.
If you still feel foggy, dizzy, or detached in the morning, do not drive – contact your provider.
Arrange your ride before the day of treatment. Staff cannot permit you to drive, and you will not be able to proceed with treatment without a transportation plan.
Friend or family member: Give a pickup window rather than a fixed time, since discharge follows the observation period.
Have a backup person in case plans change.
Rideshare or taxi: Convenient if you can wait safely and someone helps you into the car.
Avoid biking, scooter riding, motorcycle riding, or long walks if you are sedated or unsteady.
In the intensive early phase, you will need this plan on multiple days each week – treat transportation like part of the prescription.
Treat the rest of the day as quiet recovery.
Do:
Keep your driver on call until you are cleared, then rest in a quiet space at home.
Hydrate and eat a light meal if you feel hungry.
Take your oral antidepressant as usual, unless told otherwise.
Keep the next day’s plans light until you know how you feel in the morning.
Don’t:
Drive, ride a bike, or operate heavy equipment until the next day.
Make important financial, legal, or personal decisions while judgment may be off.
Consume alcohol or take other sedating medications without clearing them with your provider.
Return to work that requires driving or heavy focus the same day.
Most side effects are mild and resolve quickly, but contact your provider if you notice:
Side effects that are unusually severe or worsening after you get home.
Dizziness that leads to a fall, ongoing vomiting, chest discomfort, or extreme confusion.
Thoughts of harming yourself, or a mood that feels darker after treatment.
Still feeling sedated, detached, or unsafe to drive the next morning.
Ready to explore Spravato treatment or looking for a provider closer to home? Search our online directory, TMS Therapy Near Me, to find Spravato providers in your area and compare options for treatment-resistant depression care. Financing options are available for Spravato, making it easier to start your treatment journey.
You cannot drive on the day you receive Spravato. You stay for monitoring, leave with a driver, and wait until the next day after a restful night of sleep before you consider driving.
Arrange a ride for every visit, including backup.
Keep the rest of the treatment day quiet – skip machinery, alcohol, and major decisions.
Call the team if you feel worse at home or still feel unsafe the next morning.
Spravato offers new hope for many people with treatment-resistant depression. Following this protocol – especially the driving rule – keeps each treatment day safe, calm, and focused on feeling better.
So, can you drive after Spravato treatment? The answer is no. Not on treatment day, and not until you have slept and feel clear the next morning. Arrange your ride, protect the rest of your day, and stay out of the driver’s seat while the medicine works.
About the Author
TMS Therapy Near Me
September 30, 2026
